Breaking News, Promotions & Moves

OctAlgos Therapeutics Inc.

Dr. Ganesh Iyer has been appointed president and chief executive officer, OctAlgos Therapeutics Inc., effective immediately.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dr. Ganesh Iyer has been appointed president and chief executive officer, OctAlgos Therapeutics Inc., effective immediately. “We were incredibly fortunate to have attracted such a uniquely qualified executive as Dr. Iyer to lead Algos,” said Gary Smaby, Algos board chair and managing partner for Quatris Fund, the company’s lead investor. “Dr. Iyer possesses the rare combination of scientific expertise and business acumen needed to lead Algos in the deployment of the Co...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters